Dr Reddy's Laboratories has received approval from Health Canada to sell a generic version of the diabetes drug semaglutide, making it the first company to get market authorisation for a generic semaglutide injection in Canada and the first in a G7 country.
Recent controversies at major IT firms like TCS and Infosys have highlighted a persistent gap between workplace conduct policies and their implementation in corporate India. While companies assert zero tolerance for harassment and discrimination, employees and experts point to uneven enforcement and the need to embed ethical behaviour into organisational culture.
Recent controversies at major IT firms like TCS and Infosys have highlighted a persistent gap between workplace conduct policies and their implementation in corporate India. While companies assert zero tolerance for harassment and discrimination, employees and experts point to uneven enforcement and the need to embed ethical behaviour into organisational culture.
The post, markedly different from its usual X feed -- typically focused on low-cost tariff plans and anti-spam measures -- appears to ride on Samay Raina's popularity.
Indian realty developers are contemplating price increases for ongoing and upcoming projects to offset margin pressures caused by rising input costs and supply chain disruptions, exacerbated by the West Asia conflict. Input and labour costs have surged by 5-12%, directly impacting developer margins, especially for under-construction projects.
Ongoing geopolitical tensions in West Asia have slowed deal momentum in Dubai's luxury residential market, but Indian high-net-worth individuals (HNIs) are not exiting their marquee assets, with any 'discounted' resale deals attributed to investor liquidity stress rather than geopolitical flight.
The inauguration of Noida International Airport (NIA) is set to significantly increase property values in micro-markets along the Yamuna Expressway, with projections indicating a 28 per cent rise for plots and 22 per cent for apartments over the next two years, according to Colliers.
'Travellers are considering safer and more stable destinations.'
Sunil Bharti Mittal, 68, will retire as chairman of Airtel Africa in July after the conclusion of this year's annual general meeting (AGM), the board of the African arm of India's second-largest telecom service provider Bharti Airtel said in a statement to the exchanges on Wednesday.
Inspections conducted across 49 entities including pharmacies, wholesalers, and clinics to detect violations and misleading marketing practices.
At the heart of this debate is Section 3(d) of the Patents Act, a safeguard designed to prevent drugmakers from extending monopoly protection through trivial modifications to existing medicines.
Escalating geopolitical tensions in West Asia are prompting investors with exposure to Dubai's real estate market to reassess their portfolios. And, in this rejig, India is emerging as a stable destination for capital investment and long-term growth.
While the introduction of branded generics is likely to accelerate volumes for GLP-1 agonists, value growth may moderate because of price erosion.
The outreach comes amid a drop in Indian student enrolments in management programmes at American universities last year, following changes to US student visa policies.
'Any promotional activity carried out under the pretext of disease awareness, influencer engagement, corporate campaigns, or similar activities that create brand recall/product visibility of the prescription shall also be treated as violations.'
The government has intensified its Study in India programme and is working closely with universities and states to achieve this goal.
Reliance Jio is aiming to be one of the first scalable token service providers in the world by deeply adopting and integrating artificial intelligence (AI) into its operations, said Jio Platforms group chief executive officer (CEO) Mathew Oommen at the Mobile World Congress in Barcelona.
Abbott will exclusively distribute and market Extensior in the country, becoming the second company to secure sole distribution rights for Novo's semaglutide portfolio in India, after Emcure Pharma.
The Centre has allowed companies to begin lab testing immediately after filing applications instead of waiting for detailed scrutiny, in a move to expedite approvals for manufacture, or import of new drugs.
'On national security issues, there can be no compromise.'
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances